Literature DB >> 646341

Synthesis and antibiotic properties of chloramphenicol reduction products.

M D Corbett, B R Chipko.   

Abstract

Analogs of chloramphenicol were prepared for the first time in which the nitro group was replaced by hydroxylamine, nitroso, hydroxamic acid, methyl hydroxamate, and O-acetyl hydroxamate functional groups. These compounds were tested for antibiotic activity in order to determine whether the antibiotic activity of chloramphenicol is mediated by one or more of these potential metabolites of chloramphenicol. None of these analogs was as active as chloramphenicol against the four test organisms, and two of the compounds were essentially devoid of activity. The significance of these findings with regard to the importance of the nitro group to the biological activity of chloramphenicol is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 646341      PMCID: PMC352213          DOI: 10.1128/AAC.13.2.193

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

Review 1.  CHLORAMPHENICOL TOXICITY: CLINICAL FEATURES AND PATHOGENESIS.

Authors:  A A YUNIS; G R BLOOMBERG
Journal:  Prog Hematol       Date:  1964

2.  The mechanism of microsomal and mitochondrial nitroreductase. Electron spin resonance evidence for nitroaromatic free radical intermediates.

Authors:  R P Mason; J L Holtzman
Journal:  Biochemistry       Date:  1975-04-22       Impact factor: 3.162

3.  Oxygen inhibition of nitroreductase: electron transfer from nitro radical-anions to oxygen.

Authors:  P Wardman; E D Clarke
Journal:  Biochem Biophys Res Commun       Date:  1976-04-19       Impact factor: 3.575

Review 4.  Biochemical formation and pharmacological, toxicological, and pathological properties of hydroxylamines and hydroxamic acids.

Authors:  J H Weisburger; E K Weisburger
Journal:  Pharmacol Rev       Date:  1973-03       Impact factor: 25.468

5.  Structure-activity relationship of chloramphenicols.

Authors:  C Hansch; K Nakamoto; M Gorin; P Denisevich; E R Garret; S M Heman-Ackah; C H Won
Journal:  J Med Chem       Date:  1973-08       Impact factor: 7.446

6.  Covalent binding of drugs to tissue macromolecules as a biochemical mechanism of drug toxicities with special emphasis on chloramphenicol and thiamphenicol.

Authors:  G Krishna
Journal:  Postgrad Med J       Date:  1974-10       Impact factor: 2.401

7.  The relative participation of liver microsomal amine oxidase and cytochrome P-450 in N-demethylation reactions.

Authors:  R A Prough; D M Ziegler
Journal:  Arch Biochem Biophys       Date:  1977-04-30       Impact factor: 4.013

8.  N-phenylglycolhydroxamate production by the action of transketolase on nitrosobenzene.

Authors:  M D Corbett; B R Chipko
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

9.  Comparative studies on the N-oxidation of aniline and N,N-dimethylaniline by rabbit liver microsomes.

Authors:  P Hlavica; M Kehl
Journal:  Xenobiotica       Date:  1976-11       Impact factor: 1.908

10.  Action of the N-trifluoroacetyl analogue of D-chloramphenicol.

Authors:  K B Freeman
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

View more
  3 in total

1.  CmlI is an N-oxygenase in the biosynthesis of chloramphenicol.

Authors:  Haige Lu; Emmanuel Chanco; Huimin Zhao
Journal:  Tetrahedron       Date:  2012-09-16       Impact factor: 2.457

2.  Novel functions of an iron-sulfur flavoprotein from Trichomonas vaginalis hydrogenosomes.

Authors:  Tamara Smutná; Katerina Pilarová; Ján Tarábek; Jan Tachezy; Ivan Hrdý
Journal:  Antimicrob Agents Chemother       Date:  2014-03-24       Impact factor: 5.191

3.  Scalable and Selective β-Hydroxy-α-Amino Acid Synthesis Catalyzed by Promiscuous l-Threonine Transaldolase ObiH.

Authors:  Tyler J Doyon; Prasanth Kumar; Sierra Thein; Maeve Kim; Abigail Stitgen; Abbigail M Grieger; Cormac Madigan; Patrick H Willoughby; Andrew R Buller
Journal:  Chembiochem       Date:  2021-11-15       Impact factor: 3.164

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.